Is my portfolio
One Report to Answer all your Questions!
Zydus Lifesciences Ltd.
BSE: 532321 | NSE: ZYDUSLIFE
Mid Cap | Pharmaceuticals & Drugs
864.25
0.80 (0.09%) Cadila Healthcare - Quaterly Results
Date: 29-10-2021
The revenue declined to Rs. 20089.00 millions for the quarter ended September 2021 as compared to Rs. 20569.00 millions during the corresponding quarter last year.A radical decline of -97.02% was reported in the net profit of the company for the quarter ended September 2021 to Rs. 141.00 millions from Rs. 4730.00 millions.Operating Profit reported a sharp decline to 5537.00 millions from 6884.00 millions in the corresponding previous quarter.
(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202109 | 202009 | % Var | 202109 | 202009 | % Var | 202103 | 202003 | % Var | |
| Sales | 20089.00 | 20569.00 | -2.33 | 41323.00 | 38528.00 | 7.25 | 77904.00 | 63474.00 | 22.73 |
| Other Income | 694.00 | 608.00 | 14.14 | 991.00 | 808.00 | 22.65 | 789.00 | 8494.00 | -90.71 |
| PBIDT | 5537.00 | 6884.00 | -19.57 | 12010.00 | 12976.00 | -7.44 | 23980.00 | 22725.00 | 5.52 |
| Interest | 241.00 | 149.00 | 61.74 | 683.00 | 348.00 | 96.26 | 709.00 | 2339.00 | -69.69 |
| PBDT | 2103.00 | 6735.00 | -68.78 | 8134.00 | 12628.00 | -35.59 | 21396.00 | 19866.00 | 7.70 |
| Depreciation | 1192.00 | 1121.00 | 6.33 | 2359.00 | 2230.00 | 5.78 | 4511.00 | 4289.00 | 5.18 |
| PBT | 911.00 | 5614.00 | -83.77 | 5775.00 | 10398.00 | -44.46 | 16885.00 | 15577.00 | 8.40 |
| TAX | 770.00 | 884.00 | -12.90 | 1635.00 | 1686.00 | -3.02 | 2123.00 | 2041.00 | 4.02 |
| Deferred Tax | 43.00 | -111.00 | -138.74 | 58.00 | -150.00 | -138.67 | -910.00 | 400.00 | -327.50 |
| PAT | 141.00 | 4730.00 | -97.02 | 4140.00 | 8712.00 | -52.48 | 14762.00 | 13536.00 | 9.06 |
| Equity | 1024.00 | 1024.00 | 0.00 | 1024.00 | 1024.00 | 0.00 | 1024.00 | 1024.00 | 0.00 |
| PBIDTM(%) | 27.56 | 33.47 | -17.65 | 29.06 | 33.68 | -13.70 | 30.78 | 35.80 | -14.02 |